1. Seyam, M.S., H.A. Gabr, Z.A. Salama, M.A. Mokhles, R.N. Marzaban and A.F. Soli-Man, 2015. Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus. Turk. J. Gastroenterol., 26: 511-516.
   Direct Link  |  
2. Talaat, R.M., T.A. Salem, S. El‐Masry, A. Imbarek, M. Mokhles and A. Abdel‐Aziz, 2014. Circulating pro‐and anti‐angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma. J. Med. Virol., 86: 1120-1129.
   CrossRef  |  Direct Link  |  
3. Mokhles, A., H.Rasmy, F.A. Shaaban, E. Salama, H. Gabr, G.A. Abdel-Latif and A.M. Metwaly, 2014. Studying the possible risk factors for HBV infection within HBV vaccinated subjects. Eur. J. Sci. Res., 116: 573-583.
4. Mokhles, M.A., M.M. Tawfeek, S.M. Tawfeek and D.F. Ayoub, 2013. Insulin resistance and Hepatitis C virus infection: Risk factors and correlation to the degree of liver injury. J. Applied Sci. Res., 9: 1999-2006.
5. Mokhles, M., R.F. El-Folly, O. Elbahr, R. Saied, E. Halim, D. Abd and N.E. Saad, 2013. Impact of systemic inflammatory response syndrome (SIRS) on hospitalized cirrhotic patients. Int. J. Acad. Res., 5: 49-56.
   Direct Link  |  
6. Mokhles, M., H. Rasmy, F.A. Shaaban, N.A. Emara and H.M. Imam et al., 2013. Evaluation of the efficacy of the Egyptian program for hepatitis B virus vaccination: A cross sectional national survey. Eur. J. Sci. Res., 116: 434-447.
7. Hamdy, M., M. Mokhles and D. Fikry, 2013. Chronic Hcv infection and hemosiderosis among Egyptian thalassemia patients: The role of homa index. JAC, 24: 219-224.
   CrossRef  |  
8. Abd El Moez, A.T., M.A. Mokhles and E.H. Allam, 2013. Depression within Hepatitis C virus patients: A case control study. J. Applied Sci. Res., 9: 2019-2025.
9. Mokhles, M., A. Tohamy, W. Sharaf, H. Rasmy and A. Ibrahim, 2012. Hepcidin and chronic hepatitis C virus: Exploring the controversy Reda El Wakil,. Aust. J. Basic Applied Sci., 6: 558-565.
10. Mokhles, M., A. Abd El Moez, H. Raslan, S. Tawfeek, A. Amin and T. Ramzy, 2012. Clinical phenotype of hepatitis c virus associated diabetes mellitus within Egyptian patients. J. Med. Biomed. Sci., 3: 58-64.
11. Mokhles, M., R. El Ashry, M. Sedky, N. Emara, M. Rasheed and M. El-Wassef, 2009. Long term efficacy of hepatitis B vaccine among high risk multiple blood transfusion children in Egypt. J. Applied Sci. Res., 5: 2504-2510.
12. Salama, Z., A. Nabil, M. El-Raziky, M. Mokhles and A. Omaia, 2008. Serum selenium concentrations in Egyptian chronic liver disease patients. Afro-Arab Liver J., 7: 21-25.
13. Mokhles, M., M.A. Abd El Wahhab, M. Tawfik, W. Ezzat, K. Gamil and M. Ibrahim, 2007. Detection of aflatoxin among hepatocellular carcinoma patients in Egypt. Pak. J. Biol. Sci., 10: 1422-1429.
    CrossRef  |  Direct Link  |  
14. Ezzat, W.M., H.M. Raslan, A. Elsherbiny, M. Mokhles, M.M. Ahmed, N. Abd El-Ghaffar and E. Abdel Rasheed, 2007. Bone Mineral density and bone turnover markers in chronic liver disease. J. Med. Sci., 7: 748-750.
15. Mokhles, M., M. Tawfik and A.A.K. Abou Arab, 2006. Detection of pesticides in blood of hepatocellular carcinoma (HCC) Hepatitis C virus (HCV) infected male patients in Egypt. Sc. J. Az. Med. Fac., 27: 1115-1125.
16. Mokhles, M., A. Anwar, W.M. Ezzat and H.M. Raslan, 2006. Blood lead concentrations in patients with hepatitis C. Med. J. Cairo Univ., 75: 9-13. 2006. Blood lead concentrations in patients with hepatitis C. Med. J. Cairo Univ., 75: 9-13.
17. Mokhles, M. and T. Ramzy, 2006. Level of thrombin activable fibrinolysis inhibitor in chronic liver disease patients. Med. J. Cairo Univ., 74: 55-58.
18. El-Garem, H., M. Mokhles and E. El Sayed, 2006. Endoscopic management of bile duct strictures in kasr El-Aini gastrointestinal endoscopy unit. Med. J. Cairo Univ., 74: 233-238.
19. Mokhles, M. and N.A. El Ghaffar, 2004. Prevalence of dislipidaemia among Non-Alcoholic fatty liver disease patients with normal ALT level. Sci. J. Az. Med. Fac., 25: 1753-1761.